Cory Berkland
Founder at Adare Pharmaceuticals Usa, Inc.
Profile
Cory Berkland is the founder of Aravas, Inc. (founded in 2007) and Adare Pharmaceuticals Usa, Inc. (founded in 2008), where he holds the title of Chief Scientific Officer.
He currently holds positions as Chairman at Orion Bioscience, Inc. and Director at Bond Biosciences, Inc. He previously held the title of Professor at the University of Kansas.
Berkland received his doctorate degree from the University of Illinois.
Cory Berkland active positions
| Companies | Position | Start |
|---|---|---|
Adare Pharmaceuticals Usa, Inc.
 Adare Pharmaceuticals Usa, Inc. Miscellaneous Commercial ServicesCommercial Services Adare Pharmaceuticals Usa, Inc. engages in the development of controlled-release delivery systems for the pharmaceutical food and beverages, chemical, and consumer products industries. The company was founded by Bo Fishback and Cory Berkland in 2008 and is headquartered in Lenexa, KS. | Founder | 2007-12-31 |
Bond Biosciences, Inc.
 Bond Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Bond Biosciences, Inc. engages in healthcare business. It focuses on small developing molecule based therapeutics for preventing iron absorption. The company is headquartered in New York, NY. | Director/Board Member | - |
Orion Bioscience, Inc.
 Orion Bioscience, Inc. BiotechnologyHealth Technology Orion Bioscience, Inc. is a bioscience company. The company is based in Omaha, NE. The company was founded in 2012. Joshua Sestak has been the CEO of the company since 2012. | Chairman | - |
Former positions of Cory Berkland
| Companies | Position | End |
|---|---|---|
| University of Kansas | Corporate Officer/Principal | - |
Aravas, Inc.
 Aravas, Inc. Pharmaceuticals: MajorHealth Technology Aravas, Inc. develops innovative drugs for the treatment of serious and life-threatening conditions. It develops dry powder formulations for various therapeutic molecules, including antibiotics, corticosteroids, nucleic acids, and insoluble and soluble molecules. The firm’s products include AeroVanc, an inhaled dry powder form of vancomycin in a capsule-based inhaler to treat methicillin-resistant staphylococcus aureus infections in patients with cystic fibrosis or other lung-compromising conditions; and AeroCort, a high performance inhaled corticosteroid product for the treatment of asthma in children. The company was founded by Cory Berkland, Chris Marich, Robert N. Neville, Taneli Jouhikainen, Chal Lenge and George Laurence in March 2007 and is headquartered in Austin, TX. | Founder | - |
Training of Cory Berkland
| University of Illinois | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Adare Pharmaceuticals Usa, Inc.
Adare Pharmaceuticals Usa, Inc. Miscellaneous Commercial ServicesCommercial Services Adare Pharmaceuticals Usa, Inc. engages in the development of controlled-release delivery systems for the pharmaceutical food and beverages, chemical, and consumer products industries. The company was founded by Bo Fishback and Cory Berkland in 2008 and is headquartered in Lenexa, KS. | Commercial Services |
Aravas, Inc.
Aravas, Inc. Pharmaceuticals: MajorHealth Technology Aravas, Inc. develops innovative drugs for the treatment of serious and life-threatening conditions. It develops dry powder formulations for various therapeutic molecules, including antibiotics, corticosteroids, nucleic acids, and insoluble and soluble molecules. The firm’s products include AeroVanc, an inhaled dry powder form of vancomycin in a capsule-based inhaler to treat methicillin-resistant staphylococcus aureus infections in patients with cystic fibrosis or other lung-compromising conditions; and AeroCort, a high performance inhaled corticosteroid product for the treatment of asthma in children. The company was founded by Cory Berkland, Chris Marich, Robert N. Neville, Taneli Jouhikainen, Chal Lenge and George Laurence in March 2007 and is headquartered in Austin, TX. | Health Technology |
Bond Biosciences, Inc.
Bond Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Bond Biosciences, Inc. engages in healthcare business. It focuses on small developing molecule based therapeutics for preventing iron absorption. The company is headquartered in New York, NY. | Health Technology |
Orion Bioscience, Inc.
Orion Bioscience, Inc. BiotechnologyHealth Technology Orion Bioscience, Inc. is a bioscience company. The company is based in Omaha, NE. The company was founded in 2012. Joshua Sestak has been the CEO of the company since 2012. | Health Technology |
- Stock Market
- Insiders
- Cory Berkland
